BETA

IPO registrations (S-1, F-1) · Registrants

Altimmune, Inc.

SEC CIK
1326190 · filings on EDGAR ↗
Former names
PHARMATHENE, INC (2007–2017); HEALTHCARE ACQUISITION CORP (2005–2007)
Registration
Form S-1, first filed 2005-05-06, last 2018-09-26; 2 initial registrations, 6 amendments
Outcome
Final prospectus filed 2010-04-08; declared effective 2008-01-29
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
350 MOUNT KEMBLE AVENUE, SUITE 1001, Morristown, NJ 07960
EIN
20-2726770
Ticker
ALT (Nasdaq)
EDGAR entity type
operating
Insiders and CEO pay
Altimmune, Inc. on the corporate pages

Offering terms

Final price
$1.50 per share (424B4 filed 2010-04-08, an initial public offering)
Shares sold
1,666,668
Gross proceeds
$2,500,002 before underwriting discounts and any over-allotment option
Listing
NYSE American under the symbol PIP
Lead underwriters
Roth Capital Partners

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 24

FiledFormWhat it isName as filedEDGAR
2005-05-06S-1S-1 (registration)HEALTHCARE ACQUISITION CORP0001144204-05-014353 ↗
2005-06-10S-1/AS-1/A (amendment)HEALTHCARE ACQUISITION CORP0001144204-05-018564 ↗
2005-07-12S-1/AS-1/A (amendment)HEALTHCARE ACQUISITION CORP0001125282-05-003665 ↗
2005-07-26S-1/AS-1/A (amendment)HEALTHCARE ACQUISITION CORP0000950116-05-002520 ↗
2005-07-27S-1/AS-1/A (amendment)HEALTHCARE ACQUISITION CORP0001125282-05-003892 ↗
2008-01-29EFFECTEFFECT (declared effective)PHARMATHENE, INC9999999995-08-000327 ↗
2009-02-10EFFECTEFFECT (declared effective)PHARMATHENE, INC9999999995-09-000336 ↗
2009-02-10EFFECTEFFECT (declared effective)PHARMATHENE, INC9999999995-09-000343 ↗
2009-02-12EFFECTEFFECT (declared effective)PHARMATHENE, INC9999999995-09-000384 ↗
2009-11-25EFFECTEFFECT (declared effective)PHARMATHENE, INC9999999995-09-003296 ↗
2010-04-08424B4424B4 (final prospectus)PHARMATHENE, INC0001144204-10-019093 ↗
2010-07-21424B4424B4 (final prospectus)PHARMATHENE, INC0001144204-10-038714 ↗
2011-07-27EFFECTEFFECT (declared effective)PHARMATHENE, INC9999999995-11-002295 ↗
2011-09-21EFFECTEFFECT (declared effective)PHARMATHENE, INC9999999995-11-002774 ↗
2013-10-29EFFECTEFFECT (declared effective)PHARMATHENE, INC9999999995-13-003102 ↗
2014-05-30EFFECTEFFECT (declared effective)PHARMATHENE, INC9999999995-14-001631 ↗
2017-03-31EFFECTEFFECT (declared effective)PHARMATHENE, INC9999999995-17-000715 ↗
2017-04-06EFFECTEFFECT (declared effective)PHARMATHENE, INC9999999995-17-000756 ↗
2018-07-30S-1S-1 (registration)Altimmune, Inc.0001193125-18-231679 ↗
2018-08-17S-1/AS-1/A (amendment)Altimmune, Inc.0001193125-18-251733 ↗
2018-09-26S-1/AS-1/A (amendment)Altimmune, Inc.0001193125-18-284095 ↗
2018-09-27EFFECTEFFECT (declared effective)Altimmune, Inc.9999999995-18-002478 ↗
2018-10-01424B4424B4 (final prospectus)Altimmune, Inc.0001193125-18-289729 ↗
2019-04-12EFFECTEFFECT (declared effective)Altimmune, Inc.9999999995-19-000701 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2005-07-27S-1/Aregistration statement9,000,000-NYSE American HAQ.U3primary document; shares headline, underwriting table 1, cover names 2document ↗
2010-04-08424B4final prospectus$1.501,666,668$2,500,002NYSE American PIP1primary document; price sentence, shares headline, proceeds table, cover names 1document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Berger Edward BDirector; Other22007person page Fuzzy
KINLEY MATTHEW PDirector,Officer; OtherPresident & Treasurer72007
PAPPAJOHN JOHNDirector; Director,OfficerChairman and Secretary212007–2011
SCHAFFER DERACE LDirector; Director,Officer; OtherVice Chairman and CEO382007–2018
ENGLANDER ISRAEL ATenPercentOwner22007
MILLENCO, L.L.C.TenPercentOwner22007
MILLENNIUM MANAGEMENT, L.L.C.TenPercentOwner22007
AGUIAR ERICOther; TenPercentOwner22007
CAVANAUGH JAMES HDirector,TenPercentOwner; Other122007–2010
EVNIN LUKEOther; TenPercentOwner52007–2010
GADICKE ANSBERTOther; TenPercentOwner72007–2010
GALAKATOS NICHOLASOther; TenPercentOwner52007–2010
HealthCare Partners VII, L.P.Other; TenPercentOwner52007–2010
HEALTHCARE VENTURES VII LPOther; TenPercentOwner52007–2010
HENNER DENNISOther; TenPercentOwner52007–2010
LAWLOR AUGUSTINEOther; TenPercentOwner52007–2010
LITTLECHILD JOHN WOther; TenPercentOwner52007–2010
Mirabelli ChristopherOther; TenPercentOwner52007–2010
MPM Asset Management Investors 2004 BVIII LLCOther; TenPercentOwner52007–2010
MPM BIOVENTURES III GMBH & CO. Beteiligungs KGOther; TenPercentOwner52007–2010
MPM BIOVENTURES III GP L.P.Other; TenPercentOwner52007–2010
MPM BIOVENTURES III LLCOther; TenPercentOwner52007–2010
MPM BIOVENTURES III L.P.Other; TenPercentOwner52007–2010
MPM BIOVENTURES III PARALLEL FUND, L.P.Other; TenPercentOwner52007–2010
MPM BIOVENTURES III QP LPOther; TenPercentOwner52007–2010
Schellhammer Wayne AOther12007
SIMON NICHOLAS J IIIOther; TenPercentOwner52007–2010
STEINMETZ MICHAELOther; TenPercentOwner52007–2010
WERNER HAROLD ROther; TenPercentOwner52007–2010
WHEELER KURTOther; TenPercentOwner52007–2010
CZEREPAK ELIZABETHDirector; OfficerCFO and EVP Corp. Development; See Remarks72007–2017
WRIGHT DAVID PDirector,Officer; Director,OfficerOther; OfficerOtherChief Executive Officer; Chief Executive Officer; Pres&CEO/Member Sec. 13(d) Grp; President and CEO; President & CEO122007–2009
St Peter StevenDirector172007–2017
Camut Christopher COfficerChief Financial Officer; VP, Chief Financial Officer; VP, Gov't Contracts52007–2010person page Fuzzy
Cook Francesca MOfficerSVP, Policy & Gov't Affairs; VP, Policy & Gov't Affairs; VP, Policy & Gov't. Affairs; VP, Policy & GVMNT Affairs122007–2014
MORGES WAYNEOfficerSVP, Reg. Affairs & Quality; SVP, Regulatory Affairs & Qual; VP, Regulatory Affairs; VP, Regulatory Affairs & Qual72007–2014
RICHMAN ERIC IDirector; Director,Officer; OfficerPresident and CEO; President and Interim CEO; President & CEO; See Remarks; Sr. VP, Business Development; SVP, Business Development252007–2016
Riddle Valerie DOfficerSVP, Medical Director; VP, Medical Director92007–2011
GILL JOHNDirector; Director,OfficerPresident and CEO312007–2026
McCleary JoelDirector132007–2015
Fusco JoanOfficerSenior VP, Operations; Sr Vice President, Operations; SVP, Operations72008–2010
Karp Jordan POfficerSenior VP, General Counsel; Sr. V-P and General Counsel; SVP, General Counsel102008–2012
Price KevinOfficerPresident-Pharmathene UK, Ltd.; President - PharmAthene UK,Ltd; President-PharmAthene UK Ltd42008–2009
Reinhart Charles A. IIIOfficerSenior Vice President and CFO; SVP, Chief Financial Officer32009–2010
Runge Jeffrey W.Director142009–2017
FUERST THOMAS RICHARDOfficerChief Scientific Officer; EVP, Chief Scientific Officer; SVP, Chief Scientific Officer72010–2011
SAYARE MITCHELDirector262010–2026
MACNEILL PHILIPOfficerCFO; Controller and PAO; VP, CFO, Treasurer, Secretary62011–2016
MARKISON BRIAN ADirector62011–2015
CHANG LINDA LOfficerSVP & CFO; SVP, CFO & Secretary62011–2015
FROHLICH PHILTenPercentOwner42013–2016
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.TenPercentOwner42013–2016
Jones Jeffrey MichaelOfficerCOO22015
Drutz DavidDirector222017–2024
Enright WilliamDirector,OfficerPresident and CEO; See Remarks72017–2018
Hodges PhilipDirector152017–2026
NOVARTIS AGTenPercentOwner142017–2018
Novartis Bioventures LtdTenPercentOwner142017–2018
Paradigm Venture Partners, L.P.TenPercentOwner22017
Redmont VAXN Capital Holdings, LLCDirector; TenPercentOwner32017
Redmont Venture Partners, Inc.TenPercentOwner22017
Roberts M ScotOfficerChief Scientific Officer332017–2026
Schafer KlausDirector162017–2026
Tasker SybilOfficerChief Medical Officer; See Remarks82017–2019
Truffle Capital S.A.S.TenPercentOwner62017–2018
Brown William MichaelOfficerActing Chief Financial Officer; Chief Financial Officer82018–2021
Pisano WayneDirector152018–2026
Garg Vipin KDirector; Director,OfficerChief Financial Officer; President and CEO; President & CEO582018–2026
Harris Matthew ScottDirector; OfficerChief Medical Officer232019–2025
Collier David JTenPercentOwner12020
VELOCITY PHARMACEUTICAL HOLDINGS LLCTenPercentOwner22020
Velocity Pharma Management, LLCTenPercentOwner12020
Watson James FTenPercentOwner12020
Jorkasky DianeDirector112020–2026
Koh Bong YTenPercentOwner42020–2021
Shah Nimish PTenPercentOwner42020–2021
Venrock Healthcare Capital Partners III, L.P.TenPercentOwner42020–2021
Venrock Healthcare Capital Partners II, L.P.TenPercentOwner42020–2021
VHCP Co-Investment Holdings III, LLCTenPercentOwner42020–2021
VHCP Co-Investment Holdings II, LLCTenPercentOwner42020–2021
VHCP Management III, LLCTenPercentOwner42020–2021
VHCP Management II, LLCTenPercentOwner42020–2021
Eisenstadt Richard IOfficerChief Financial Officer112022–2024
Jordt Raymond MOfficerChief Business Officer152023–2026
Sohn Catherine A.Director92023–2026
Shutterly AndrewOfficerActing Chief Financial Officer; See Remarks22024
WEAVER GREGORY LOfficerChief Financial Officer92024–2026
Durso Jerome BenedictDirector; Director,OfficerCEO-elect; President and CEO82025–2026
Lawver Teri LDirector42025–2026person page Fuzzy
Richardson Linda MOfficerChief Commercial Officer32025–2026
Arbet-Engels ChristopheOfficerChief Medical Officer22025

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
SEC filerAltimmune, Inc.SEC filers (EDGAR)CIK (EXACT)
Form 5500 plan sponsorALTIMMUNE, INC.EIN (EXACT)
Person pageChristopher C CamutPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer)
Person pageEdward B BergerPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Other)
Person pageTeri L LawverPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, NJ first:

More with this interest.

In other datasets, the same topic (Health) in NJ:

Interests: Pharmaceutical Preparations · Health